Weight loss medicines in England
A briefing on the licensing, regulation and supply of new weight loss medications in England.

This Debate Pack has been prepared ahead of the debate on the Implications of the Accelerated Access Review for cystic fibrosis and other conditions, to be held in Westminster Hall on Tuesday 13 December at 9.30am. The subject for the debate has been chosen by the Backbench Business Committee, following a representation made by Ian Austin, Ben Howlett and Kerry McCarthy.
Implications of the Accelerated Access Review (220 KB , PDF)
Implications of the Accelerated Access Review (220 KB , PDF)
A briefing on the licensing, regulation and supply of new weight loss medications in England.
Find out about the causes and consequences of medicines shortages, and UK Government actions in response to supply disruption affecting human medicines.
Interactive dashboard showing data on GPs in England, including patient to GP ratios, the number of GPs, and a map of GP practices